Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Poster Listings<br />
Session 107 CROI <strong>2013</strong><br />
c Wednesday, 2:30-4 pm; Hall B2<br />
Session 107–Poster Abstracts<br />
ART: Too Early or Too Late? Or Better Late than Never!<br />
560 Kinetics of Resting Memory B Cells in Naïve HIV + Patients<br />
Treated during Primary and Chronic HIV Infection<br />
Marco Ripa*, S Pensieroso, S Nozza, L Galli, G Scarlatti,<br />
and G Tambussi<br />
San Raffaele Sci Inst, Milan, Italy<br />
561 Predictors of Virologic Suppression in Persons Who Start<br />
ART during Primary HIV Infection<br />
Maile Karris* 1 , Y-T Kao 1 , F Vaida 1 , C Spina 1,2 , D Richman 1,2 , S Little 1,2 ,<br />
and D Smith 1,2<br />
1 Univ of California, San Diego, La Jolla, US and 2 VA San Diego Hlthcare<br />
System, CA, US<br />
562 Early Intermittent ART in HIV + ������������������������<br />
mm � ��������������������������������������<br />
Lionel Piroth* 1 , L Moinot 2 , P Yeni 3 , J Reynes 4 , P-M Girard 5 ,<br />
X Anglaret 2 , A Taieb 2 , B Autran 6 , C Rouzioux 7 , C Fagard 2 , and ANRS 141<br />
TIPI Trial Study Group<br />
1 Hosp Bocage, Univ de Bourgogne, Dijon, France;; 2 INSERM U897, Univ<br />
Bordeaux, France;; 3 Hosp Bichat-Claude Bernard, Paris, France;; 4 Hosp<br />
Gui De Chauliac, Montpellier, France;; 5 Hosp St-Antoine, Paris, France;;<br />
6 Hosp Pitie-Salpetriere, Paris, France;; and 7 Hosp Necker, Paris, France<br />
42 � 20th Conference on Retroviruses and Opportunistic Infections<br />
c Wednesday, 2:30-4 pm; Hall B2<br />
Session 108–Poster Abstracts<br />
ART: Host and Viral Determinants of Outcome<br />
569 European Mitochondrial Haplogroups Are Associated with<br />
��� + T Cell Recovery in HIV + Patients on cART<br />
M Guzman-Fulgencio 1 , Juan Berenguer* 2 , A Fernandez-Rodriguez 1 ,<br />
D Micheloud 2 , M GarciaAlvarez 1 , MA Jimenez-Sousa 1 , JM Bellon 2 ,<br />
J Cosin 2 , T Aldamiz-Echevarria 2 , and S Resino 1<br />
1 Natl Ctr of Microbio, Inst de Salud Carlos III, Majadahonda, Madrid,<br />
Spain and 2 Hosp Gen Univ Gregorio Maranon, Madrid, Spain<br />
570 Impact of HIV + ���������������������������������������<br />
Response and ARV Pharmacokinetics<br />
MP Le 1 , K Champenois 2 , C Charpentier 1 , R Landman 1 , V Joly 1 , P Yeni 1 ,<br />
D Descamps 1 , Y Yazdanpanah 1 , and Gilles Peytavin* 1<br />
1 APHP, EA4409 Univ Paris 7 Diderot, Bichat-Claude Bernard Hosp,<br />
France and 2 Equipe Atip/Avenir INSERM U738, Univ Paris 7 Diderot,<br />
France<br />
563� ������������������������������������������������������������<br />
in Very Early Compared to Chronic HIV Infection<br />
Frederick Hecht* 1 , W Hartogensis1 , S Saha1 , S Little2 , M Markowitz3 ,<br />
J Margolick4 , B Walker5 , V Jain1 , C Pilcher1 , P Bacchetti1 , and Acute<br />
Infection Early Disease Res Prgm<br />
1 2 Univ of California, San Francisco, US;; Univ of California, San<br />
Diego, US;; 3Aaron Diamond AIDS Res Ctr, New York, NY, US;; 4Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US;; and<br />
5Massachusetts Gen Hosp, Boston, US<br />
564� �������������������������������������������������<br />
����������������������������������������������������������<br />
Sophie Jose* 1 , S Fidler2 , C Sabin1 , and UK Collaborative HIV Cohort<br />
Study<br />
1 2 Univ Coll London, UK and St Marys Hosp, London, UK<br />
565� ���������������������������������������������������������<br />
and Immune Activation in HIV + ������������������������<br />
Mohammad-Ali Jenabian* 1 , M Patel1 , C Kanagaratham1 , D Radzioch1 ,<br />
P Ancuta2 , I Kema3 , R Thomas4 , J Singer5 , J Angel6 , and J-P Routy7 1 2 Res Inst of McGill Univ Hlth Ctr, Montreal, Canada;; CHUM Res Ctr,<br />
Montreal, Canada;; 3Univ Med Ctr, Univ of Groningen, The Netherlands;;<br />
4 5 Lactuel Med Clin, Montreal, Canada;; CIHR Canadian HIV Trials<br />
Network, Vancouver;; 6Ottawa Hosp Res Inst, Canada;; and 7 571 Weight Change at 1 Month of ART Is Associated with<br />
������������������������������������������������<br />
HIV<br />
Royal<br />
Victoria Hosp, McGill Univ Hlth Ctr, Montreal, Canada<br />
+ Adult Cohort<br />
Christopher Sudfeld* 1 , S Isanaka1 , F Mugusi2 , S Aboud2 , M Wang1 ,<br />
G Chalamilla3 , and W Fawzi1 1 2 Harvard Sch of Publ Hlth, Boston, MA, US;; Muhimbili Univ of Hlth<br />
and Allied Sci, Dar es Salaam, Tanzania;; and 3Mgmt and Devt for Hlth,<br />
Dar es Salaam, Tanzania<br />
572� �����������������������������������������������<br />
Response to Initial cART: A European Multicohort Study<br />
Linda Wittkop on behalf of EuroCoord-CHAIN Subtype Project Team<br />
INSERM U897-Epidemiologie-Biostatistique, Univ Bordeaux and Univ<br />
Hosp, France<br />
573 Can the Veterans Aging Cohort Study Index Improve Clinical<br />
Judgment?<br />
Amy Justice* 1,2 , J Tate1,2 , S Brown3,4 , C Gibert5,6 , M Rodriguez-<br />
Barradas7,8 , D Rimland9,10 , K Akgun1,2 , and K Bryant11 1 2 Yale Univ, New Haven, CT, US;; VA Connecticut Hlthcare System,<br />
West Haven, US;; 3James J Peters VAMC, New York NY, US;; 4Mt Sinai<br />
Sch of Med, New York, NY, US;; 5George Washington Univ Sch of Med,<br />
Washington, DC, US;; 6Washington DC VAMC, US;; 7Baylor Coll of Med,<br />
Houston TX, US;; 8Michael E DeBakey VAMC, Houston, TX, US;; 9Emory Univ Sch of Med, Atlanta, GA, US;; 10Atlanta VAMC, GA, US;; and 11Natl Inst on Alcohol Abuse and Alcoholism, Bethesda, MD, US<br />
574� ������������������������������������������������<br />
��������������������������������������������<br />
Adriana Ammassari*, I Abbate, P Lorenzini, G Rozera, S Ottou,<br />
C Pinnetti, A Amendola, M Zaccarelli, A Antinori, and MR Capobianchi<br />
Natl Inst for Infectious Disease L Spallanzani, Rome, Italy<br />
566 Maraviroc + Raltegravir Dual Therapy in Aviremic HIV +<br />
Patients with Lipodystrophy: Results from the ROCnRAL<br />
Agence Nationale de la Recherche 157 Study<br />
Christine Katlama* 1 , L Assoumou1 , M-A Valantin1 , C Duvivier2 ,<br />
C Soulie1 , L Chablais1 , G Pialoux3 , P Mercie4 , G Peytavin5 , A-G Marcelin1 ,<br />
and ANRS 157 Study Group<br />
1 2 INSERM U943, Paris VI Pitie Salpetriere Univ Hosp, France;; Inst<br />
Pasteur Paris, Necker Hosp, France;; 3Tenon, Paris VI Univ, France;;<br />
4 5 INSERM U897 Hosp St-Andre, Bordeaux, France;; and Bichat Univ<br />
Hosp, Paris, France<br />
567� ����������������������������������������������������������<br />
�����������������������������������������������������������<br />
of MIDAS<br />
Babafemi Taiwo* 1 , D Lu2 , S Swindells3 , B Berzins1 , P Ryscavage4 ,<br />
J Lalezari5 , J Castro6 , O Adeyemi7 , D Kuritzkes2 , J Eron8 , and MIDAS<br />
Study Team<br />
1 2 Northwestern Univ, Chicago, IL, US;; Harvard Univ, Cambridge, MA,<br />
US;; 3Univ of Nebraska, Omaha, US;; 4Univ of Maryland, Baltimore, US;;<br />
5 6 7 Quest Clin Res, San Francisco, CA, US;; Univ of Miami, FL, US;; CORE<br />
Ctr, Chicago, IL, US;; and 8Univ of North Carolina at Chapel Hill, US<br />
568� �������������������������������������������������������<br />
Expectancy of ART-treated HIV + Individuals Compared with<br />
the General Population<br />
Margaret May* 1 , A Mocroft2 , J Guest3 , H Crane4 , P Reiss5 ,<br />
A dArminio Monforte6 , P Labarga7 , J-C Wasmuth8 , S Ingle1 , R Hogg9,10 ,<br />
and ART Cohort Collaboration<br />
1 2 3 Univ of Bristol, UK;; Univ Coll London Med Sch, UK;; Atlanta VAMC,<br />
Decatur, GA, US;; 4Univ of Washington Sch of Med, Seattle, US;; 5Univ of Amsterdam, The Netherlands;; 6Univ of Milan, Italy;; 7Hosp Carlos III,<br />
Madrid, Spain;; 8 575 A Low HIV DNA Level in Peripheral Blood Mononuclear<br />
������������������������������������������������<br />
�������������������������������������������<br />
L Assoumou<br />
Rheinische Friedrich-Wilhelms-Univ Bonn, Germany;;<br />
9 10 BC Ctr for Excellence in HIV/AIDS, Vancouver, Canada;; and Simon<br />
Fraser Univ, Burnaby, Canada<br />
1,2 , L Weiss3,4 , C Piketty3 , M Burgard5 , A Melard5 , J-M Ragnaud6 ,<br />
P-M Girard7 , D Costagliola1,2 , Christine Rouzioux* 4,5 , and ANRS 116<br />
SALTO Study Group<br />
1 2 INSERM U943, Paris, France;; UPMC Univ Paris 06, UMR S 943,<br />
France;; 3AP-HP Hosp Europeen Georges Pompidou, Paris, France;;<br />
4 5 Univ Rene Descartes Paris 05, France;; AP-HP Hosp Necker Paris,<br />
France;; 6Hosp Pellegrin, Bordeaux, France;; and 7AP-HP Hosp<br />
St-Antoine, Paris, France<br />
576 Viremia Copy-years as a Measure of Viral Load Burden<br />
and Associated Mortality Risk among ART Patients:<br />
���������������������������<br />
Alana Brennan* 1,2 , M Maskew2 , I Sanne2,3 , and M Fox1,2,4 1 2 Ctr for Global Hlth and Devt, Boston Univ, MA, US;; Sch of Clin Med,<br />
Faculty of Hlth Sci, Univ of the Witwatersrand, Johannesburg, South<br />
Africa;; 3Right to Care, Johannesburg, South Africa;; and 4Boston Univ Sch<br />
of Publ Hlth, MA, US<br />
577 Mortality of Treated HIV-1 + Individuals according to Viral<br />
������������������������������������������������<br />
Margaret May* 1 , M Gill2 , R Harrigan3 , M Klein4 , P Reiss5 , A Mocroft6 ,<br />
A dArminio Monforte7 , R Zangerle8 , M Cavassini9 , J Sterne1 , and ART<br />
Cohort Collaboration<br />
1 2 3 Univ of Bristol, UK;; Univ of Calgary, Canada;; BC Ctr for Excellence<br />
in HIV/AIDS and Univ of British Columbia, Vancouver, Canada;; 4McGill Univ, Montreal, Canada;; 5Univ of Amsterdam, The Netherlands;; 6Univ Coll London Med Sch, UK;; 7Univ of Milan, Italy;; 8Innsbruck Med Univ,<br />
Austria;; and 9Ctr Hosp Univ Vaudois, Lausanne, Switzerland
Change language